| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.885 | 0.002 | 0.885 | Alcohol oxidase inhibitor | |||
| 0.799 | 0.002 | 0.799 | Alpha-N-acetylglucosaminidase inhibitor | |||
| 0.778 | 0.002 | 0.778 | Succinate dehydrogenase inhibitor | |||
| 0.76 | 0.005 | 0.76 | Aldehyde oxidase inhibitor | |||
| 0.736 | 0.002 | 0.736 | GABA C receptor agonist | |||
| 0.726 | 0.005 | 0.726 | Platelet antagonist | 0.279 0.06 DB02912 0.339 0.041 DB04045 0.372 0.033 DB03699 | ||
| 0.712 | 0.002 | 0.712 | Porphobilinogen synthase inhibitor | |||
| 0.681 | 0.003 | 0.681 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.671 | 0.017 | 0.671 | Cyclophilin D inhibitor | |||
| 0.674 | 0.027 | 0.674 | Caspase 9 stimulant | |||
| 0.653 | 0.012 | 0.653 | Cholesterol antagonist | |||
| 0.651 | 0.01 | 0.651 | Vasodilator, peripheral | 0.316 0.089 DB02912 0.325 0.085 DB04045 0.415 0.051 DB03699 | ||
| 0.637 | 0.001 | 0.637 | Ferrochelatase inhibitor | |||
| 0.638 | 0.003 | 0.638 | Growth hormone agonist | |||
| 0.625 | 0.012 | 0.625 | 5 Hydroxytryptamine release stimulant | |||
| 0.61 | 0.01 | 0.61 | 5 Hydroxytryptamine release inhibitor | |||
| 0.599 | 0.008 | 0.599 | Hypoglycemic | |||
| 0.598 | 0.008 | 0.598 | GABA C receptor rho-3 antagonist | |||
| 0.592 | 0.01 | 0.592 | Apoptosis antagonist | 0.2 0.179 DB03699 | ||
| 0.592 | 0.011 | 0.592 | Histamine release inhibitor | |||
| 0.58 | 0.005 | 0.58 | Peroxidase inhibitor | |||
| 0.599 | 0.054 | 0.599 | Antiinflammatory | |||
| 0.54 | 0.004 | 0.54 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.544 | 0.009 | 0.544 | Superoxide dismutase inhibitor | |||
| 0.512 | 0.002 | 0.512 | Triose-phosphate isomerase inhibitor | |||
| 0.509 | 0.007 | 0.509 | Anesthetic general | |||
| 0.527 | 0.026 | 0.527 | Immunosuppressant | 0.521 0.027 DB02912 0.473 0.041 DB04045 0.487 0.037 DB03699 | ||
| 0.505 | 0.012 | 0.505 | Hypolipemic | |||
| 0.483 | 0.003 | 0.803 | Glutamate dehydrogenase inhibitor | 0.621 0.002 DB02912 0.791 0.001 DB04045 0.803 0.001 DB03699 | DB03699 | |
| 0.487 | 0.01 | 0.487 | Interleukin 2 agonist | |||
| 0.471 | 0.011 | 0.471 | Platelet aggregation inhibitor | |||
| 0.47 | 0.014 | 0.47 | Psychostimulant | 0.158 0.11 DB03699 | ||
| 0.486 | 0.031 | 0.733 | Antithrombotic | 0.633 0.013 DB02912 0.692 0.009 DB04045 0.733 0.006 DB03699 | DB03699 | |
| 0.456 | 0.003 | 0.698 | Carbamoyl phosphate synthetase inhibitor | 0.617 0.001 DB02912 0.606 0.001 DB04045 0.698 0.001 DB03699 | DB03699 | |
| 0.442 | 0.002 | 0.58 | Fumarate hydratase inhibitor | 0.227 0.003 DB02912 0.445 0.002 DB04045 0.58 0.002 DB03699 | DB03699 | |
| 0.444 | 0.008 | 0.444 | Sodium/bile acid cotransporter inhibitor | |||
| 0.446 | 0.013 | 0.446 | Interleukin agonist | |||
| 0.432 | 0.003 | 0.432 | Glutamate decarboxylase inhibitor | |||
| 0.437 | 0.008 | 0.463 | Phospholipase C inhibitor | 0.393 0.011 DB02912 0.334 0.015 DB04045 0.463 0.007 DB03699 | DB03699 | |
| 0.43 | 0.003 | 0.43 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | |||
| 0.434 | 0.018 | 0.434 | Vasodilator | 0.367 0.029 DB02912 0.353 0.032 DB04045 0.372 0.028 DB03699 | ||
| 0.405 | 0.006 | 0.405 | Insulin secretagoues | 0.154 0.07 DB04045 0.147 0.078 DB03699 | ||
| 0.402 | 0.003 | 0.987 | Adenylate kinase inhibitor | 0.979 0 DB02912 0.973 0 DB04045 0.987 0 DB03699 | DB03699 | |
| 0.396 | 0.004 | 0.396 | Catalase inhibitor | |||
| 0.45 | 0.062 | 0.45 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.39 | 0.005 | 0.39 | Cell adhesion inhibitor | |||
| 0.385 | 0.002 | 0.385 | Aconitate hydratase inhibitor | |||
| 0.383 | 0.003 | 0.977 | Phosphofructokinase-1 inhibitor | 0.957 0 DB02912 0.971 0 DB04045 0.977 0 DB03699 | DB03699 | |
| 0.377 | 0.003 | 0.44 | Argininosuccinate synthase inhibitor | 0.321 0.004 DB02912 0.44 0.002 DB04045 0.364 0.003 DB03699 | DB04045 | |
| 0.407 | 0.039 | 0.407 | Spasmolytic | |||
| 0.372 | 0.004 | 0.372 | GABA C receptor antagonist | |||
| 0.386 | 0.023 | 0.871 | DNA synthesis inhibitor | 0.842 0.003 DB02912 0.829 0.003 DB04045 0.871 0.002 DB03699 | DB03699 | |
| 0.376 | 0.014 | 0.376 | Platelet adhesion inhibitor | 0.132 0.128 DB02912 0.136 0.124 DB04045 0.153 0.102 DB03699 | ||
| 0.368 | 0.007 | 0.629 | Aldehyde dehydrogenase inhibitor | 0.56 0.004 DB02912 0.437 0.005 DB04045 0.629 0.003 DB03699 | DB03699 | |
| 0.368 | 0.007 | 0.368 | Gastrin inhibitor | |||
| 0.383 | 0.031 | 0.383 | Calcium channel activator | |||
| 0.374 | 0.027 | 0.374 | Angiogenesis stimulant | 0.147 0.124 DB03699 | ||
| 0.346 | 0.004 | 0.346 | Phenylalanine 4-hydroxylase inhibitor | |||
| 0.36 | 0.018 | 0.36 | Non-steroidal antiinflammatory agent | |||
| 0.4 | 0.06 | 0.4 | Toll-Like receptor agonist | |||
| 0.352 | 0.013 | 0.352 | Lipocortins synthesis antagonist | |||
| 0.341 | 0.003 | 0.54 | Biliverdin reductase inhibitor | 0.48 0.001 DB02912 0.458 0.002 DB04045 0.54 0.001 DB03699 | DB03699 | |
| 0.354 | 0.016 | 0.354 | Thrombolytic | |||
| 0.366 | 0.029 | 0.366 | Insulysin inhibitor | |||
| 0.355 | 0.024 | 0.355 | Cyclic AMP phosphodiesterase inhibitor | |||
| 0.34 | 0.01 | 0.34 | Insulin sensitizer | |||
| 0.383 | 0.055 | 0.871 | Immunostimulant | 0.791 0.004 DB02912 0.833 0.003 DB04045 0.871 0.003 DB03699 | DB03699 | |
| 0.402 | 0.076 | 0.495 | Antibacterial | 0.416 0.07 DB02912 0.495 0.042 DB04045 0.434 0.063 DB03699 | DB04045 | |
| 0.371 | 0.046 | 0.471 | Vasodilator, coronary | 0.471 0.02 DB02912 0.456 0.022 DB04045 0.44 0.025 DB03699 | DB02912 | |
| 0.389 | 0.066 | 0.389 | Transcription factor NF kappa B inhibitor | |||
| 0.325 | 0.004 | 0.325 | Creatine kinase inhibitor | |||
| 0.333 | 0.018 | 0.333 | Diuretic | |||
| 0.379 | 0.068 | 0.379 | Toll-Like receptor 7 agonist | |||
| 0.313 | 0.006 | 0.313 | Histidine decarboxylase inhibitor | |||
| 0.324 | 0.017 | 0.562 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.547 0.003 DB02912 0.479 0.004 DB04045 0.562 0.003 DB03699 | DB03699 | |
| 0.302 | 0.005 | 0.6 | Alcohol dehydrogenase inhibitor | 0.534 0.003 DB02912 0.499 0.003 DB04045 0.6 0.002 DB03699 | DB03699 | |
| 0.301 | 0.005 | 0.301 | Cell adhesion molecule inhibitor | |||
| 0.323 | 0.028 | 0.623 | RNA-directed DNA polymerase inhibitor | 0.623 0.004 DB02912 0.579 0.006 DB04045 0.601 0.005 DB03699 | DB02912 | |
| 0.302 | 0.008 | 0.795 | Expectorant | 0.572 0.003 DB02912 0.549 0.003 DB04045 0.795 0.002 DB03699 | DB03699 | |
| 0.383 | 0.093 | 0.383 | Calcium channel L-type activator | |||
| 0.294 | 0.004 | 0.294 | Electrolyte absorption antagonist | |||
| 0.293 | 0.004 | 0.293 | Photosensitizer | |||
| 0.298 | 0.01 | 0.48 | UDP-glucose 4-epimerase inhibitor | 0.48 0.003 DB02912 0.401 0.006 DB04045 0.441 0.004 DB03699 | DB02912 | |
| 0.29 | 0.007 | 0.616 | NADH dehydrogenase inhibitor | 0.615 0.002 DB02912 0.567 0.002 DB04045 0.616 0.002 DB03699 | DB03699 | |
| 0.302 | 0.019 | 0.302 | Interferon gamma antagonist | |||
| 0.293 | 0.012 | 0.293 | Cholesterol synthesis inhibitor | |||
| 0.283 | 0.004 | 0.283 | GABA C receptor rho-1 antagonist | |||
| 0.296 | 0.017 | 0.296 | Protein kinase stimulant | |||
| 0.281 | 0.005 | 0.288 | Mucolytic | 0.185 0.017 DB02912 0.182 0.018 DB04045 0.288 0.004 DB03699 | DB03699 | |
| 0.305 | 0.028 | 0.305 | Hepatoprotectant | 0.146 0.114 DB02912 0.146 0.114 DB04045 0.181 0.079 DB03699 | ||
| 0.299 | 0.025 | 0.299 | Peptidyltransferase inhibitor | 0.219 0.078 DB02912 0.213 0.083 DB04045 0.218 0.078 DB03699 | ||
| 0.285 | 0.011 | 0.285 | Cell wall synthesis inhibitor | 0.146 0.069 DB04045 0.13 0.086 DB03699 | ||
| 0.283 | 0.011 | 0.283 | Cystathionine beta-synthase inhibitor | |||
| 0.292 | 0.02 | 0.292 | Neurotrophic factor enhancer | |||
| 0.277 | 0.005 | 0.277 | Integrin antagonist | |||
| 0.321 | 0.05 | 0.321 | DNA damaging | |||
| 0.274 | 0.003 | 0.274 | Adenylate cyclase stimulant | 0.152 0.06 DB02912 0.153 0.058 DB04045 0.169 0.036 DB03699 | ||
| 0.288 | 0.02 | 0.288 | Amylase inhibitor | |||
| 0.277 | 0.01 | 0.277 | Aminopeptidase B inhibitor | |||
| 0.272 | 0.008 | 0.272 | GABA C receptor rho-2 antagonist | |||
| 0.269 | 0.005 | 0.718 | Ornithine carbamoyltransferase inhibitor | 0.635 0.002 DB02912 0.718 0.001 DB04045 0.637 0.002 DB03699 | DB04045 | |
| 0.274 | 0.01 | 0.274 | Interleukin 4 antagonist | |||
| 0.318 | 0.055 | 0.318 | Antioxidant | |||
| 0.265 | 0.004 | 0.265 | Arachidonic acid antagonist | |||
| 0.278 | 0.017 | 0.278 | Phospholipase A2 inhibitor | |||
| 0.279 | 0.023 | 0.279 | Protein-tyrosine phosphatase inhibitor | |||
| 0.303 | 0.047 | 0.303 | Interleukin antagonist | |||
| 0.26 | 0.005 | 0.26 | Prostaglandin antagonist | |||
| 0.256 | 0.002 | 0.256 | Glutamate (mGluR6) antagonist | |||
| 0.27 | 0.017 | 0.685 | Adenylate cyclase inhibitor | 0.675 0.002 DB02912 0.671 0.002 DB04045 0.685 0.002 DB03699 | DB03699 | |
| 0.321 | 0.071 | 0.713 | Immunomodulator | 0.713 0.005 DB02912 0.692 0.005 DB04045 0.708 0.005 DB03699 | DB02912 | |
| 0.253 | 0.004 | 0.253 | Prolactin inhibitor | |||
| 0.261 | 0.015 | 0.514 | DNA polymerase I inhibitor | 0.514 0.004 DB02912 0.496 0.004 DB04045 0.509 0.004 DB03699 | DB02912 | |
| 0.25 | 0.005 | 0.25 | Peroxisome proliferator-activated receptor gamma agonist | |||
| 0.247 | 0.003 | 0.901 | Acyl-CoA dehydrogenase inhibitor | 0.879 0 DB02912 0.712 0 DB04045 0.901 0 DB03699 | DB03699 | |
| 0.246 | 0.005 | 0.246 | Prostaglandin EP2 antagonist | |||
| 0.25 | 0.009 | 0.25 | Toll-Like receptor 2 antagonist | |||
| 0.259 | 0.019 | 0.259 | Neurotensin receptor agonist | |||
| 0.262 | 0.023 | 0.262 | Bone formation stimulant | |||
| 0.307 | 0.068 | 0.307 | Lipoxygenase inhibitor | |||
| 0.242 | 0.005 | 0.242 | Aminopeptidase I inhibitor | |||
| 0.274 | 0.037 | 0.274 | DNA methyltransferase I inhibitor | |||
| 0.24 | 0.004 | 0.24 | GABA aminotransferase inhibitor | |||
| 0.239 | 0.003 | 0.239 | Glycine receptor agonist | |||
| 0.247 | 0.011 | 0.247 | Catenin beta inhibitor | |||
| 0.257 | 0.022 | 0.257 | Interleukin 6 antagonist | |||
| 0.26 | 0.026 | 0.26 | Nitric-oxide synthase stimulant | |||
| 0.284 | 0.052 | 0.284 | Pyruvate kinase inhibitor | |||
| 0.325 | 0.099 | 0.325 | Calpain 2 inhibitor | |||
| 0.229 | 0.006 | 0.229 | Folate antagonist | 0.092 0.083 DB02912 0.093 0.08 DB04045 0.118 0.04 DB03699 | ||
| 0.278 | 0.058 | 0.278 | Free radical scavenger | |||
| 0.226 | 0.007 | 0.226 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.233 | 0.019 | 0.233 | Alkylator | 0.135 0.056 DB02912 0.102 0.086 DB04045 0.175 0.035 DB03699 | ||
| 0.214 | 0.003 | 0.214 | Ca2+-transporting ATPase inhibitor | |||
| 0.241 | 0.03 | 0.241 | Melanin inhibitor | |||
| 0.215 | 0.004 | 0.215 | Sphingosine 1-phosphate receptor 5 agonist | |||
| 0.217 | 0.006 | 0.217 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.239 | 0.028 | 0.239 | Antipruritic | |||
| 0.255 | 0.045 | 0.687 | DNA methylase inhibitor | 0.622 0.004 DB02912 0.562 0.004 DB04045 0.687 0.003 DB03699 | DB03699 | |
| 0.216 | 0.007 | 0.216 | Keratolytic | |||
| 0.213 | 0.005 | 0.213 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.212 | 0.005 | 0.212 | DOPA decarboxylase inhibitor | |||
| 0.228 | 0.022 | 0.228 | Protein-tyrosine phosphatase 1B inhibitor | |||
| 0.21 | 0.004 | 0.21 | NMDA receptor agonist | |||
| 0.207 | 0.004 | 0.207 | Glutamate release inhibitor | |||
| 0.214 | 0.014 | 0.214 | Carbonic anhydrase III inhibitor | |||
| 0.2 | 0.002 | 0.2 | Glucose-6-phosphate isomerase inhibitor | |||
| 0.211 | 0.013 | 0.211 | Mediator release inhibitor | |||
| 0.236 | 0.042 | 0.236 | Anticoagulant | |||
| 0.216 | 0.023 | 0.216 | Mannose-6-phosphate isomerase inhibitor | |||
| 0.21 | 0.018 | 0.21 | Microtubule formation inhibitor | |||
| 0.195 | 0.004 | 0.195 | Peroxisome proliferator-activated receptor delta antagonist | |||
| 0.195 | 0.004 | 0.195 | Sphingosine 1-phosphate receptor 4 agonist | |||
| 0.206 | 0.017 | 0.206 | Cyclooxygenase 3 inhibitor | |||
| 0.217 | 0.029 | 0.217 | Monophenol monooxygenase inhibitor | |||
| 0.27 | 0.083 | 0.27 | Hypoxia-inducible factor 1 alpha inhibitor | |||
| 0.199 | 0.012 | 0.199 | Vanilloid 1 agonist | |||
| 0.261 | 0.075 | 0.261 | Transcription factor STAT3 inhibitor | |||
| 0.194 | 0.01 | 0.194 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.248 | 0.067 | 0.248 | Calpain inhibitor | |||
| 0.202 | 0.022 | 0.202 | Cathepsin H inhibitor | |||
| 0.183 | 0.004 | 0.183 | GABA B receptor agonist | |||
| 0.19 | 0.011 | 0.19 | Caspase 3 inhibitor | |||
| 0.183 | 0.005 | 0.183 | Ornithine decarboxylase inhibitor | |||
| 0.183 | 0.008 | 0.183 | GP IIb/IIIa receptor antagonist | |||
| 0.205 | 0.031 | 0.205 | Anesthetic local | |||
| 0.18 | 0.006 | 0.18 | Leukotriene synthesis inhibitor | |||
| 0.181 | 0.007 | 0.181 | Anabolic | |||
| 0.186 | 0.014 | 0.186 | TRPA1 agonist | |||
| 0.178 | 0.009 | 0.178 | Interleukin 1 beta converting enzyme inhibitor | |||
| 0.324 | 0.156 | 0.351 | Apoptosis agonist | 0.292 0.178 DB02912 0.351 0.138 DB03699 | DB03699 | |
| 0.237 | 0.07 | 0.237 | Neuropeptide Y2 antagonist | |||
| 0.178 | 0.013 | 0.248 | Heat shock protein 70 antagonist | 0.219 0.005 DB02912 0.222 0.005 DB04045 0.248 0.004 DB03699 | DB03699 | |
| 0.201 | 0.037 | 0.201 | ATPase inhibitor | |||
| 0.168 | 0.005 | 0.168 | Glycine receptor antagonist | |||
| 0.249 | 0.088 | 0.249 | Transcription factor STAT inhibitor | |||
| 0.164 | 0.005 | 0.268 | Purinergic P2X1 antagonist | 0.268 0.002 DB02912 0.217 0.003 DB04045 0.263 0.002 DB03699 | DB02912 | |
| 0.162 | 0.005 | 0.162 | Caspase 9 inhibitor | |||
| 0.166 | 0.009 | 0.166 | Glutathione S-transferase inhibitor | |||
| 0.174 | 0.018 | 0.174 | Cathepsin G inhibitor | |||
| 0.243 | 0.087 | 0.243 | Cardiotonic | 0.176 0.144 DB03699 | ||
| 0.169 | 0.013 | 0.169 | ABCA1 expression enhancer | |||
| 0.159 | 0.004 | 0.159 | Glucagon-like peptide 1 receptor antagonist | |||
| 0.172 | 0.018 | 0.172 | Uric acid excretion stimulant | |||
| 0.163 | 0.009 | 0.163 | Interferon agonist | |||
| 0.156 | 0.005 | 0.156 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.265 | 0.114 | 0.265 | Thyroid hormone antagonist | |||
| 0.16 | 0.01 | 0.16 | Carbonic anhydrase stimulant | |||
| 0.156 | 0.008 | 0.407 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.407 0.002 DB02912 0.352 0.003 DB04045 0.39 0.002 DB03699 | DB02912 | |
| 0.151 | 0.004 | 0.151 | Glutamate (mGluR3) antagonist | |||
| 0.155 | 0.01 | 0.155 | Aldose reductase inhibitor | |||
| 0.155 | 0.01 | 0.155 | Toll-Like receptor 2 agonist | |||
| 0.152 | 0.01 | 0.152 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.155 | 0.014 | 0.155 | Macrophage migration inhibitory factor inhibitor | |||
| 0.179 | 0.037 | 0.179 | CF transmembrane conductance regulator agonist | |||
| 0.171 | 0.03 | 0.171 | Chelator | |||
| 0.185 | 0.045 | 0.185 | Hexokinase inhibitor | 0.159 0.068 DB02912 0.142 0.089 DB03699 | ||
| 0.145 | 0.005 | 0.145 | Plasminogen activator inhibitor antagonist | |||
| 0.173 | 0.033 | 0.173 | Farnesoid X receptor antagonist | |||
| 0.142 | 0.004 | 0.142 | Free fatty acid receptor 1 agonist | |||
| 0.145 | 0.011 | 0.145 | Leukotriene antagonist | |||
| 0.139 | 0.005 | 0.139 | Estrogen-related receptor beta agonist | |||
| 0.161 | 0.028 | 0.161 | Interleukin 8 antagonist | |||
| 0.152 | 0.02 | 0.171 | Toll-Like receptor 4 antagonist | 0.169 0.013 DB02912 0.17 0.013 DB04045 0.171 0.012 DB03699 | DB03699 | |
| 0.18 | 0.048 | 0.18 | Thiol protease inhibitor | |||
| 0.136 | 0.005 | 0.136 | Prostaglandin F2 alpha antagonist | |||
| 0.163 | 0.034 | 0.163 | Pregnane X receptor agonist | |||
| 0.139 | 0.01 | 0.139 | Bile acid receptor antagonist | |||
| 0.153 | 0.026 | 0.153 | AMP-activated protein kinase stimulant | |||
| 0.128 | 0.002 | 0.128 | Kainate receptor agonist | |||
| 0.188 | 0.062 | 0.188 | Dual specificity phosphatase inhibitor | |||
| 0.16 | 0.034 | 0.16 | 5-Lipoxygenase inhibitor | |||
| 0.128 | 0.003 | 0.128 | Glutamate (mGluR1a) agonist | |||
| 0.131 | 0.006 | 0.131 | NMDA receptor glycine site agonist | |||
| 0.128 | 0.004 | 0.128 | Retinoid X alpha receptor agonist | |||
| 0.128 | 0.005 | 0.128 | Phospholipase D inhibitor | |||
| 0.148 | 0.025 | 0.148 | Sphingomyelinase inhibitor | |||
| 0.136 | 0.013 | 0.751 | Antimetabolite | 0.594 0.002 DB02912 0.647 0.002 DB04045 0.751 0.001 DB03699 | DB03699 | |
| 0.131 | 0.01 | 0.131 | Sphingosine 1-phosphate receptor antagonist | |||
| 0.124 | 0.002 | 0.124 | Glutamate (mGluR8) agonist | |||
| 0.136 | 0.015 | 0.136 | CDC25A inhibitor | |||
| 0.143 | 0.022 | 0.143 | Carbonic anhydrase VI inhibitor | |||
| 0.149 | 0.027 | 0.149 | Gastric antisecretory | |||
| 0.125 | 0.003 | 0.125 | Lysophosphatidic acid 3 receptor antagonist | |||
| 0.126 | 0.005 | 0.126 | Vanilloid 4 agonist | |||
| 0.169 | 0.049 | 0.169 | Hemostatic | |||
| 0.124 | 0.004 | 0.124 | Glutamate (mGluR7) antagonist | |||
| 0.137 | 0.018 | 0.137 | Glutamate (mGluR7) agonist | |||
| 0.123 | 0.004 | 0.123 | Glutamate (mGluR4) antagonist | |||
| 0.121 | 0.005 | 0.121 | Alpha-mannosidase inhibitor | |||
| 0.133 | 0.017 | 0.133 | Interleukin 5 antagonist | |||
| 0.171 | 0.055 | 0.171 | Lipid peroxidase inhibitor | |||
| 0.12 | 0.004 | 0.12 | Glutamate (mGluR group III) antagonist | |||
| 0.121 | 0.005 | 0.121 | Mannosidase inhibitor | |||
| 0.12 | 0.004 | 0.12 | AMPA 4 receptor antagonist | |||
| 0.122 | 0.008 | 0.122 | 5-Alpha-reductase inhibitor | |||
| 0.12 | 0.007 | 0.965 | Purinergic P2Y antagonist | 0.948 0 DB02912 0.937 0.001 DB04045 0.965 0 DB03699 | DB03699 | |
| 0.115 | 0.003 | 0.115 | Membrane dipeptidase inhibitor | |||
| 0.117 | 0.004 | 0.117 | Prostaglandin D2 antagonist | |||
| 0.115 | 0.004 | 0.115 | Purinergic P2Y12 antagonist | 0.071 0.005 DB02912 0.064 0.005 DB04045 0.082 0.005 DB03699 | ||
| 0.19 | 0.08 | 0.19 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.237 | 0.127 | 0.237 | Thyroid hormone beta antagonist | |||
| 0.168 | 0.06 | 0.168 | Acetylcholine M1 receptor antagonist | |||
| 0.181 | 0.073 | 0.181 | Dual specificity phosphatase 3 inhibitor | |||
| 0.132 | 0.024 | 0.132 | Thioredoxin inhibitor | |||
| 0.112 | 0.004 | 0.112 | Lysophosphatidic acid 2 receptor antagonist | |||
| 0.113 | 0.005 | 0.113 | Sphingosine 1-phosphate receptor 3 antagonist | |||
| 0.111 | 0.004 | 0.111 | Kainate receptor 2 antagonist | |||
| 0.111 | 0.004 | 0.111 | Retinoid X receptor agonist | |||
| 0.132 | 0.026 | 0.132 | Carbonic anhydrase XIII inhibitor | |||
| 0.109 | 0.004 | 0.109 | Glutamate (mGluR1) agonist | |||
| 0.143 | 0.037 | 0.143 | Nav1.4 sodium channel blocker | |||
| 0.109 | 0.005 | 0.109 | MDM2 inhibitor | |||
| 0.108 | 0.004 | 0.108 | Lipocortins synthesis agonist | |||
| 0.139 | 0.035 | 0.139 | Carbonic anhydrase XV inhibitor | |||
| 0.113 | 0.009 | 0.113 | Interferon inducer | |||
| 0.126 | 0.022 | 0.126 | Inducible nitric-oxide synthase inhibitor | |||
| 0.108 | 0.005 | 0.108 | Integrin alpha4 antagonist | |||
| 0.105 | 0.005 | 0.105 | Prostaglandin agonist | |||
| 0.104 | 0.005 | 0.104 | Vitronectin receptor antagonist | |||
| 0.106 | 0.007 | 0.106 | Exportin-1 inhibitor | |||
| 0.14 | 0.042 | 0.14 | Falcipain 3 inhibitor | |||
| 0.114 | 0.017 | 0.114 | D-Ala-D-Ala ligase inhibitor | |||
| 0.104 | 0.007 | 0.104 | Kainate receptor antagonist | |||
| 0.107 | 0.011 | 0.107 | Peroxisome proliferator-activated receptor alpha agonist | |||
| 0.104 | 0.008 | 0.104 | Sphingosine 1-phosphate receptor 1 antagonist | |||
| 0.1 | 0.005 | 0.1 | 5-Alpha-reductase 2 inhibitor | |||
| 0.105 | 0.009 | 0.105 | Thromboxane antagonist | |||
| 0.115 | 0.02 | 0.115 | Na+ K+ transporting ATPase inhibitor | |||
| 0.109 | 0.014 | 0.109 | Neuraminidase (influenza) inhibitor | |||
| 0.098 | 0.004 | 0.098 | Arginase inhibitor | |||
| 0.111 | 0.019 | 0.111 | Caspase 7 inhibitor | |||
| 0.096 | 0.004 | 0.096 | ATP citrate lysase inhibitor | |||
| 0.105 | 0.013 | 0.105 | Peroxisome proliferator-activated receptor gamma antagonist | |||
| 0.105 | 0.014 | 0.105 | Neuraminidase inhibitor | |||
| 0.128 | 0.037 | 0.128 | Acetylcholine release stimulant | |||
| 0.101 | 0.01 | 0.101 | NMDA receptor subunit 3B antagonist | |||
| 0.184 | 0.094 | 0.184 | Histone acetyltransferase inhibitor | |||
| 0.114 | 0.023 | 0.114 | Selectin antagonist | |||
| 0.094 | 0.004 | 0.094 | Pregnane X receptor antagonist | |||
| 0.115 | 0.024 | 0.128 | Hematopoietic | 0.116 0.024 DB02912 0.114 0.025 DB04045 0.128 0.019 DB03699 | DB03699 | |
| 0.143 | 0.053 | 0.143 | Antibacterial (Helicobacter pylori) | |||
| 0.108 | 0.018 | 0.359 | Ribonucleoside-diphosphate reductase inhibitor | 0.28 0.004 DB02912 0.349 0.003 DB04045 0.359 0.003 DB03699 | DB03699 | |
| 0.093 | 0.003 | 0.093 | Free fatty acid receptor 1 antagonist | |||
| 0.097 | 0.007 | 0.097 | Thromboxane synthase inhibitor | |||
| 0.104 | 0.015 | 0.839 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.67 0.002 DB02912 0.49 0.002 DB04045 0.839 0.001 DB03699 | DB03699 | |
| 0.116 | 0.027 | 0.15 | Transcription factor NF kappa B stimulant | 0.144 0.017 DB02912 0.139 0.019 DB04045 0.15 0.016 DB03699 | DB03699 | |
| 0.093 | 0.005 | 0.093 | Leukotriene C antagonist | |||
| 0.107 | 0.019 | 0.421 | Ribonucleotide reductase inhibitor | 0.362 0.003 DB02912 0.408 0.003 DB04045 0.421 0.002 DB03699 | DB03699 | |
| 0.135 | 0.048 | 0.135 | DNA repair enzyme inhibitor | |||
| 0.138 | 0.05 | 0.138 | Beta amyloid protein antagonist | |||
| 0.121 | 0.033 | 0.121 | Androgen antagonist | |||
| 0.13 | 0.043 | 0.13 | Xanthine oxidase inhibitor | |||
| 0.091 | 0.004 | 0.091 | GABA uptake inhibitor | |||
| 0.102 | 0.015 | 0.102 | NMDA 2C receptor antagonist | |||
| 0.098 | 0.011 | 0.098 | Leukotriene B4 antagonist | |||
| 0.095 | 0.009 | 0.095 | Thromboxane A2 antagonist | |||
| 0.218 | 0.132 | 0.218 | 12-Lipoxygenase inhibitor | |||
| 0.1 | 0.014 | 0.1 | Androgen agonist | |||
| 0.1 | 0.016 | 0.1 | CDC25B inhibitor | |||
| 0.123 | 0.039 | 0.123 | Potassium channel (Ca-activated) activator | |||
| 0.09 | 0.008 | 0.09 | DNA helicase inhibitor | |||
| 0.088 | 0.005 | 0.088 | Dopamine D5 agonist | |||
| 0.114 | 0.031 | 0.114 | NAD(P)H dehydrogenase (quinone) inhibitor | |||
| 0.087 | 0.004 | 0.087 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | |||
| 0.09 | 0.008 | 0.399 | Phosphoglycerate kinase inhibitor | 0.393 0.002 DB02912 0.256 0.003 DB04045 0.399 0.002 DB03699 | DB03699 | |
| 0.094 | 0.012 | 0.094 | Carbonic anhydrase XIV inhibitor | |||
| 0.102 | 0.021 | 0.102 | Glucagon-like peptide 1 agonist | |||
| 0.086 | 0.005 | 0.086 | Prostacyclin antagonist | |||
| 0.087 | 0.007 | 0.087 | Urate transporter 1 inhibitor | |||
| 0.087 | 0.007 | 0.087 | Sphingosine 1-phosphate receptor agonist | |||
| 0.089 | 0.01 | 0.089 | NMDA receptor subunit 3A antagonist | |||
| 0.086 | 0.006 | 0.086 | AICAR transformylase inhibitor | 0.048 0.024 DB02912 0.054 0.018 DB04045 0.079 0.008 DB03699 | ||
| 0.179 | 0.1 | 0.179 | Anticonvulsant | |||
| 0.086 | 0.007 | 0.086 | VLA-4 antagonist | |||
| 0.082 | 0.004 | 0.082 | Prostaglandin EP4 agonist | |||
| 0.085 | 0.008 | 0.085 | Squalene synthetase inhibitor | |||
| 0.082 | 0.004 | 0.082 | Lysine carboxypeptidase inhibitor | |||
| 0.088 | 0.011 | 0.088 | Macrophage elastase inhibitor | |||
| 0.084 | 0.007 | 0.084 | Ryanodine receptor antagonist | |||
| 0.118 | 0.041 | 0.118 | Factor V inhibitor | |||
| 0.078 | 0.002 | 0.078 | Carbonic anhydrase X inhibitor | |||
| 0.078 | 0.002 | 0.078 | Carbonic anhydrase VIII inhibitor | |||
| 0.081 | 0.004 | 0.081 | Integrin alphaVbeta3 antagonist | |||
| 0.081 | 0.005 | 0.081 | 5-Alpha-reductase 1 inhibitor | |||
| 0.081 | 0.005 | 0.081 | Glucagon receptor antagonist | |||
| 0.132 | 0.057 | 0.132 | Proteasome inhibitor | |||
| 0.143 | 0.068 | 0.143 | Histone deacetylase SIRT1 inhibitor | |||
| 0.078 | 0.003 | 0.078 | Glutamate (mGluR3) agonist | |||
| 0.082 | 0.007 | 0.082 | Peroxisome proliferator-activated receptor delta agonist | |||
| 0.089 | 0.015 | 0.089 | Glycine transporter 2 inhibitor | |||
| 0.086 | 0.012 | 0.086 | Diacylglycerol O-acyltransferase inhibitor | |||
| 0.081 | 0.007 | 0.081 | Thymidylate synthase inhibitor | |||
| 0.085 | 0.011 | 0.085 | CD45 antagonist | |||
| 0.085 | 0.012 | 0.085 | Leukocyte elastase inhibitor | |||
| 0.078 | 0.005 | 0.078 | Geranyltranstransferase inhibitor | |||
| 0.086 | 0.012 | 0.086 | Glutamate (mGluR group III) agonist | |||
| 0.093 | 0.019 | 0.093 | S-adenosyl-L-methionine decarboxylase inhibitor | |||
| 0.077 | 0.004 | 0.077 | Retinoid X gamma receptor agonist | |||
| 0.076 | 0.004 | 0.076 | Glutamate (mGluR8) antagonist | |||
| 0.079 | 0.006 | 0.079 | GABA B receptor antagonist | |||
| 0.102 | 0.03 | 0.102 | Vanilloid agonist | |||
| 0.076 | 0.004 | 0.076 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | |||
| 0.079 | 0.007 | 0.079 | Leukotriene D4 antagonist | |||
| 0.124 | 0.053 | 0.124 | GABA receptor agonist | |||
| 0.091 | 0.02 | 0.091 | Protease 3C (Human rhinovirus) inhibitor | |||
| 0.078 | 0.006 | 0.078 | Sphingosine 1-phosphate receptor 1 agonist | |||
| 0.075 | 0.003 | 0.075 | Retinoid X receptor antagonist | |||
| 0.075 | 0.004 | 0.075 | Kynurenine 3 monooxygenase inhibitor | |||
| 0.079 | 0.009 | 0.079 | Adenine nucleotide translocase inhibitor | 0.062 0.024 DB02912 0.062 0.024 DB04045 0.063 0.024 DB03699 | ||
| 0.079 | 0.009 | 0.118 | Adenosine deaminase inhibitor | 0.118 0.004 DB02912 0.098 0.006 DB04045 0.109 0.004 DB03699 | DB02912 | |
| 0.073 | 0.004 | 0.073 | Prostaglandin D2 agonist | |||
| 0.071 | 0.003 | 0.071 | Prostaglandin F2 alpha agonist | |||
| 0.112 | 0.044 | 0.112 | Nitric-oxide synthase inhibitor | |||
| 0.081 | 0.013 | 0.081 | Angiotensin-converting enzyme inhibitor | |||
| 0.087 | 0.02 | 0.087 | Carbonic anhydrase VB inhibitor | |||
| 0.095 | 0.027 | 0.095 | Carbonic anhydrase VA inhibitor | |||
| 0.107 | 0.04 | 0.107 | Phosphodiesterase 6D inhibitor | |||
| 0.072 | 0.004 | 0.072 | Guanylate cyclase inhibitor | |||
| 0.074 | 0.008 | 0.074 | Nicotinic acid receptor agonist | |||
| 0.07 | 0.004 | 0.07 | Retinoid X beta receptor agonist | |||
| 0.073 | 0.007 | 0.073 | Caspase 2 inhibitor | |||
| 0.106 | 0.04 | 0.106 | Histamine N-methyltransferase inhibitor | |||
| 0.098 | 0.032 | 0.098 | Analgesic, opioid | |||
| 0.07 | 0.004 | 0.07 | Integrin alphaVbeta1 antagonist | |||
| 0.083 | 0.018 | 0.083 | Protein 50S ribosomal subunit inhibitor | 0.054 0.036 DB02912 0.054 0.036 DB04045 0.054 0.036 DB03699 | ||
| 0.09 | 0.025 | 0.09 | MAP kinase kinase 7 inhibitor | |||
| 0.094 | 0.029 | 0.094 | Carbonic anhydrase V inhibitor | |||
| 0.068 | 0.005 | 0.068 | Leukotriene B4 receptor 1 antagonist | |||
| 0.068 | 0.004 | 0.068 | Leukotriene C4 antagonist | |||
| 0.068 | 0.004 | 0.068 | Kainate receptor 1 antagonist | |||
| 0.107 | 0.043 | 0.107 | Calcium antagonist | |||
| 0.067 | 0.004 | 0.067 | HMG CoA reductase inhibitor | |||
| 0.066 | 0.003 | 0.066 | Lysophosphatidic acid receptor 1 agonist | |||
| 0.154 | 0.091 | 0.154 | Nitric oxide antagonist | |||
| 0.066 | 0.004 | 0.066 | Prostaglandin EP2 agonist | |||
| 0.065 | 0.004 | 0.065 | Integrin alpha1beta1 antagonist | |||
| 0.065 | 0.004 | 0.065 | Angiotensin II receptor antagonist | |||
| 0.064 | 0.003 | 0.064 | Retinoid X alpha receptor antagonist | |||
| 0.065 | 0.004 | 0.065 | Angiotensin AT1 receptor antagonist | |||
| 0.092 | 0.032 | 0.092 | CC chemokine 5 receptor agonist | |||
| 0.071 | 0.011 | 0.071 | Adenylate cyclase 1 inhibitor | |||
| 0.08 | 0.02 | 0.08 | NMDA 2A receptor antagonist | |||
| 0.064 | 0.004 | 0.064 | Prostacyclin agonist | |||
| 0.07 | 0.011 | 0.07 | Heparanase inhibitor | |||
| 0.068 | 0.009 | 0.068 | Integrin alpha5beta1 antagonist | |||
| 0.063 | 0.005 | 0.063 | Uridine phosphorylase inhibitor | |||
| 0.065 | 0.007 | 0.065 | p53 inhibitor | |||
| 0.063 | 0.005 | 0.063 | Prostaglandin E2 agonist | |||
| 0.063 | 0.005 | 0.063 | Integrin beta3 antagonist | |||
| 0.073 | 0.015 | 0.073 | Acetyl-CoA transferase 2 inhibitor | |||
| 0.063 | 0.005 | 0.063 | AMPA 3 receptor antagonist | |||
| 0.067 | 0.01 | 0.067 | Sphingosine 1-phosphate receptor 3 agonist | |||
| 0.072 | 0.016 | 0.072 | Dihydroorotate oxidase inhibitor | |||
| 0.096 | 0.04 | 0.096 | Glutamate receptor agonist | |||
| 0.086 | 0.03 | 0.086 | Elastase 1 inhibitor | |||
| 0.087 | 0.032 | 0.087 | Amidase inhibitor | |||
| 0.159 | 0.104 | 0.159 | P-glycoprotein inhibitor | |||
| 0.068 | 0.013 | 0.068 | Fructose-1,6-bisphosphatase inhibitor | |||
| 0.061 | 0.007 | 0.061 | Peroxisome proliferator-activated receptor alpha antagonist | |||
| 0.132 | 0.078 | 0.132 | Nav1.6 sodium channel blocker | |||
| 0.074 | 0.021 | 0.074 | Sphingosine kinase inhibitor | |||
| 0.079 | 0.025 | 0.079 | Maillard reaction inhibitor | |||
| 0.064 | 0.01 | 0.064 | Dihydropteroate synthase inhibitor | |||
| 0.058 | 0.005 | 0.058 | VCAM-1 antagonist | |||
| 0.058 | 0.005 | 0.058 | VCAM antagonist | |||
| 0.094 | 0.041 | 0.094 | Metalloproteinase-2 inhibitor | |||
| 0.061 | 0.008 | 0.061 | Prostaglandin EP3 antagonist | |||
| 0.151 | 0.099 | 0.151 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.127 | 0.075 | 0.127 | Toll-Like receptor antagonist | |||
| 0.068 | 0.016 | 0.068 | HCV NS3/NS4A protease inhibitor | |||
| 0.079 | 0.027 | 0.079 | Beta adrenoreceptor antagonist | |||
| 0.065 | 0.013 | 0.065 | Leukotriene A4 hydrolase inhibitor | |||
| 0.056 | 0.004 | 0.056 | Thyroid hormone agonist | |||
| 0.058 | 0.007 | 0.058 | Prostaglandin EP4 antagonist | |||
| 0.098 | 0.048 | 0.098 | NMDA receptor antagonist | |||
| 0.073 | 0.024 | 0.073 | Corticotropin releasing factor 2 receptor antagonist | |||
| 0.051 | 0.002 | 0.051 | Glutamate (mGluR6) agonist | |||
| 0.063 | 0.014 | 0.063 | Dihydroorotase inhibitor | |||
| 0.23 | 0.182 | 0.23 | 15-Lipoxygenase inhibitor | |||
| 0.057 | 0.008 | 0.057 | Integrin alpha2 antagonist | |||
| 0.051 | 0.002 | 0.051 | Retinoid X beta receptor antagonist | |||
| 0.081 | 0.032 | 0.081 | Potassium channel (Tandem pore domain) blocker | |||
| 0.061 | 0.012 | 0.061 | Cytokine production stimulant | |||
| 0.118 | 0.069 | 0.118 | Acetylcholine muscarinic antagonist | |||
| 0.052 | 0.005 | 0.052 | Tryptophan 5 hydroxylase inhibitor | |||
| 0.057 | 0.01 | 0.057 | Retinoic acid alpha receptor agonist | |||
| 0.06 | 0.013 | 0.06 | Neuraminidase (Influenza A) inhibitor | |||
| 0.054 | 0.007 | 0.054 | Liver X receptor beta antagonist | |||
| 0.052 | 0.005 | 0.052 | Methionyl aminopeptidase 1 inhibitor | |||
| 0.064 | 0.017 | 0.064 | Immunoglobulin Fc receptor antagonist | |||
| 0.049 | 0.003 | 0.049 | Vanilloid 2 agonist | |||
| 0.17 | 0.123 | 0.17 | Antiamyloidogenic | |||
| 0.066 | 0.019 | 0.066 | Complement C3a chemotactic receptor antagonist | |||
| 0.05 | 0.004 | 0.05 | Thyroid hormone alpha antagonist | |||
| 0.122 | 0.076 | 0.122 | M17 leucyl aminopeptidase inhibitor | |||
| 0.1 | 0.054 | 0.1 | Interleukin 12 antagonist | |||
| 0.048 | 0.003 | 0.048 | Lysophosphatidic acid receptor 3 agonist | |||
| 0.063 | 0.018 | 0.063 | Aldosterone antagonist | |||
| 0.063 | 0.018 | 0.063 | Squalene epoxidase inhibitor | |||
| 0.068 | 0.023 | 0.068 | Sphingosine kinase 2 inhibitor | |||
| 0.074 | 0.029 | 0.074 | Nitric oxide donor | |||
| 0.06 | 0.015 | 0.06 | Dopamine beta hydroxylase inhibitor | |||
| 0.148 | 0.103 | 0.148 | Tumour necrosis factor antagonist | |||
| 0.08 | 0.035 | 0.08 | Sirtuin 1 inhibitor | |||
| 0.123 | 0.079 | 0.123 | NADPH oxidase inhibitor | |||
| 0.054 | 0.01 | 0.054 | AMPA 1 receptor antagonist | |||
| 0.065 | 0.021 | 0.065 | Bombesin 2 receptor antagonist | |||
| 0.113 | 0.069 | 0.113 | Estrogen antagonist | |||
| 0.077 | 0.034 | 0.077 | Neutrophil collagenase inhibitor | |||
| 0.048 | 0.004 | 0.048 | Nicotinic acid receptor 2 antagonist | |||
| 0.063 | 0.02 | 0.063 | Carbonic anhydrase II stimulant | |||
| 0.093 | 0.05 | 0.093 | ATPase (Vacuolar H+) inhibitor | |||
| 0.056 | 0.013 | 0.056 | Cholecystokinin B agonist | |||
| 0.081 | 0.038 | 0.081 | Prostaglandin-E synthase inhibitor | |||
| 0.06 | 0.017 | 0.06 | Oxytocin agonist | |||
| 0.06 | 0.017 | 0.06 | Factor III inhibitor | |||
| 0.052 | 0.009 | 0.052 | Peptide deformylase inhibitor | |||
| 0.051 | 0.009 | 0.051 | Diacylglycerol O-acyltransferase 1 inhibitor | |||
| 0.056 | 0.013 | 0.056 | Dihydrofolate reductase inhibitor | |||
| 0.072 | 0.03 | 0.072 | Beta 3 adrenoreceptor antagonist | |||
| 0.05 | 0.008 | 0.05 | Vanilloid 3 antagonist | |||
| 0.069 | 0.027 | 0.069 | Potassium channel intermediate-conductance Ca-activated blocker | |||
| 0.049 | 0.007 | 0.049 | Carboxypeptidase B inhibitor | |||
| 0.08 | 0.038 | 0.08 | HIV-1 integrase inhibitor | |||
| 0.089 | 0.048 | 0.089 | mTOR complex 2 inhibitor | |||
| 0.043 | 0.002 | 0.043 | Thromboxane A2 agonist | |||
| 0.093 | 0.052 | 0.093 | Antineoplastic alkaloid | |||
| 0.044 | 0.004 | 0.044 | Prostaglandin H2 antagonist | |||
| 0.044 | 0.004 | 0.044 | Lysophosphatidic acid 1 receptor antagonist | |||
| 0.051 | 0.011 | 0.051 | AMPA 2 receptor antagonist | |||
| 0.107 | 0.067 | 0.107 | Electron transport complex I inhibitor | |||
| 0.113 | 0.073 | 0.113 | Transcription factor STAT6 inhibitor | |||
| 0.055 | 0.016 | 0.055 | Calcitonin receptor agonist | |||
| 0.042 | 0.002 | 0.042 | Thromboxane agonist | |||
| 0.045 | 0.006 | 0.045 | Integrin beta5 antagonist | |||
| 0.069 | 0.03 | 0.069 | Calcium channel P-type blocker | |||
| 0.064 | 0.026 | 0.064 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | |||
| 0.043 | 0.004 | 0.043 | G-protein-coupled receptor 120 agonist | |||
| 0.048 | 0.009 | 0.157 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.157 0.001 DB02912 0.143 0.001 DB04045 0.157 0.001 DB03699 | DB03699 | |
| 0.048 | 0.01 | 0.107 | Purinergic P2T antagonist | 0.103 0.005 DB02912 0.094 0.005 DB04045 0.107 0.005 DB03699 | DB03699 | |
| 0.066 | 0.028 | 0.066 | Estrogen agonist | |||
| 0.042 | 0.004 | 0.042 | Ileal bile acid transport inhibitor | |||
| 0.052 | 0.014 | 0.052 | Farnesoid X receptor agonist | |||
| 0.086 | 0.048 | 0.086 | Acetylcholine nicotinic antagonist | |||
| 0.083 | 0.045 | 0.083 | Estrogen receptor alpha antagonist | |||
| 0.049 | 0.011 | 0.049 | Glutamate (mGluR4) agonist | |||
| 0.042 | 0.004 | 0.042 | Retinoid X gamma receptor antagonist | |||
| 0.104 | 0.067 | 0.104 | Topoisomerase I inhibitor | |||
| 0.064 | 0.027 | 0.064 | Prostaglandin E2 antagonist | |||
| 0.045 | 0.008 | 0.045 | Epoxide hydrolase 1 inhibitor | |||
| 0.102 | 0.065 | 0.102 | Urease inhibitor | |||
| 0.053 | 0.017 | 0.053 | Liver X receptor alpha agonist | |||
| 0.053 | 0.017 | 0.119 | Thymidine kinase inhibitor | 0.119 0.005 DB02912 0.091 0.007 DB04045 0.106 0.006 DB03699 | DB02912 | |
| 0.042 | 0.006 | 0.042 | Purinergic P2Y15 antagonist | |||
| 0.124 | 0.088 | 0.124 | Neurotrophic factor | |||
| 0.04 | 0.005 | 0.04 | Leukotriene B4 receptor 2 antagonist | |||
| 0.043 | 0.008 | 0.043 | Kainate receptor 4 antagonist | |||
| 0.051 | 0.017 | 0.051 | G protein-coupled receptor agonist | |||
| 0.046 | 0.011 | 0.046 | Carnitine palmitoyltransferase inhibitor | 0.035 0.022 DB02912 0.04 0.016 DB03699 | ||
| 0.078 | 0.044 | 0.078 | Epoxide hydrolase inhibitor | |||
| 0.065 | 0.031 | 0.065 | Beta 1 adrenoreceptor antagonist | |||
| 0.054 | 0.02 | 0.054 | Benzodiazepine antagonist | |||
| 0.063 | 0.03 | 0.063 | Matrix metalloproteinase (membrane-type) inhibitor | |||
| 0.113 | 0.08 | 0.113 | Cholinergic antagonist | |||
| 0.04 | 0.007 | 0.04 | Caspase 6 inhibitor | |||
| 0.041 | 0.009 | 0.041 | Calcium-independent phospholipase A2 inhibitor | |||
| 0.05 | 0.018 | 0.05 | Nerve growth factor antagonist | |||
| 0.09 | 0.058 | 0.393 | Aminoacyl-tRNA synthetase inhibitor | 0.393 0.004 DB02912 0.385 0.004 DB04045 0.387 0.004 DB03699 | DB02912 | |
| 0.116 | 0.084 | 0.116 | Cyclooxygenase 1 inhibitor | |||
| 0.058 | 0.026 | 0.058 | Endothelin-converting enzyme inhibitor | |||
| 0.044 | 0.012 | 0.044 | Carnitine palmitoyltransferase 1 inhibitor | 0.032 0.028 DB02912 0.036 0.021 DB03699 | ||
| 0.038 | 0.006 | 0.038 | Estrogen-related receptor gamma antagonist | |||
| 0.038 | 0.006 | 0.038 | Integrin alpha4beta7 antagonist | |||
| 0.035 | 0.004 | 0.035 | Neuraminidase (Influenza B) inhibitor | |||
| 0.066 | 0.035 | 0.066 | Collagenase 3 inhibitor | |||
| 0.054 | 0.023 | 0.054 | Cholecystokinin antagonist | |||
| 0.065 | 0.034 | 0.065 | Xanthine dehydrogenase inhibitor | |||
| 0.064 | 0.033 | 0.064 | Beta 2 adrenoreceptor agonist | |||
| 0.04 | 0.009 | 0.04 | Neutral endopeptidase inhibitor | |||
| 0.036 | 0.005 | 0.036 | Aminopeptidase A inhibitor | |||
| 0.043 | 0.013 | 0.043 | Ceramide glucosyltransferase inhibitor | |||
| 0.054 | 0.024 | 0.096 | Carnitine palmitoyltransferase 1B inhibitor | 0.095 0.005 DB02912 0.082 0.007 DB04045 0.096 0.005 DB03699 | DB03699 | |
| 0.072 | 0.042 | 0.072 | Matrix metalloproteinase inhibitor | |||
| 0.053 | 0.023 | 0.053 | Microtubule stabilization | |||
| 0.057 | 0.027 | 0.057 | Beta 2 adrenoreceptor antagonist | |||
| 0.056 | 0.027 | 0.056 | Metalloproteinase-3 inhibitor | |||
| 0.047 | 0.018 | 0.047 | Heme oxygenase inhibitor | |||
| 0.06 | 0.031 | 0.06 | Glucosylceramidase inhibitor | |||
| 0.035 | 0.006 | 0.035 | Hedgehog signaling activator | |||
| 0.033 | 0.005 | 0.033 | N-Acetylated alpha-linked acidic dipeptidase inhibitor | |||
| 0.036 | 0.008 | 0.036 | Kainate receptor 5 antagonist | |||
| 0.033 | 0.004 | 0.033 | Isoleucine-tRNA ligase inhibitor | |||
| 0.047 | 0.019 | 0.047 | Sphingosine kinase 1 inhibitor | |||
| 0.078 | 0.05 | 0.078 | CYP2A6 inhibitor | |||
| 0.033 | 0.005 | 0.033 | Corticosteroid-like | |||
| 0.031 | 0.003 | 0.031 | Telomerase stimulant | |||
| 0.032 | 0.004 | 0.032 | Caspase 8 inhibitor | |||
| 0.075 | 0.048 | 0.075 | Metalloproteinase-9 inhibitor | |||
| 0.029 | 0.003 | 0.893 | Methylmalonyl-CoA mutase inhibitor | 0.503 0 DB02912 0.893 0 DB04045 0.731 0 DB03699 | DB04045 | |
| 0.036 | 0.01 | 0.036 | LFA antagonist | |||
| 0.04 | 0.014 | 0.04 | HCV NS5B polymerase inhibitor | |||
| 0.042 | 0.017 | 0.042 | RNA-directed RNA polymerase inhibitor | |||
| 0.032 | 0.007 | 0.032 | Fructose-1,6-bisphosphatase 1 inhibitor | |||
| 0.05 | 0.025 | 0.05 | Carbonic anhydrase IV inhibitor | |||
| 0.064 | 0.039 | 0.064 | HIV-1 integrase (Strand Transfer) inhibitor | |||
| 0.028 | 0.003 | 0.028 | Carbonic anhydrase XI inhibitor | |||
| 0.075 | 0.051 | 0.075 | Adenosine A3 receptor antagonist | |||
| 0.107 | 0.083 | 0.107 | Acetylcholine antagonist | |||
| 0.061 | 0.037 | 0.061 | Botulinum neurotoxin type A inhibitor | |||
| 0.052 | 0.029 | 0.126 | Phosphorylase inhibitor | 0.091 0.014 DB02912 0.078 0.017 DB04045 0.126 0.009 DB03699 | DB03699 | |
| 0.043 | 0.019 | 0.11 | Inosine monophosphate dehydrogenase inhibitor | 0.068 0.009 DB02912 0.04 0.022 DB04045 0.11 0.005 DB03699 | DB03699 | |
| 0.044 | 0.021 | 0.044 | Glutamate (mGluR group II) antagonist | |||
| 0.027 | 0.004 | 0.027 | Angiotensin AT1B receptor antagonist | |||
| 0.053 | 0.03 | 0.053 | Potassium channel (Inward rectifier) activator | |||
| 0.055 | 0.033 | 0.055 | Nicotinic alpha3beta2 receptor antagonist | |||
| 0.038 | 0.016 | 0.038 | Melatonin receptor 1A agonist | |||
| 0.043 | 0.021 | 0.043 | MAP3K5 inhibitor | |||
| 0.034 | 0.011 | 0.034 | Protocollagen prolyl hydroxylase inhibitor | |||
| 0.033 | 0.011 | 0.033 | Calcium-sensing receptor agonist | |||
| 0.027 | 0.005 | 0.027 | Nicotinic acid receptor 1 antagonist | |||
| 0.029 | 0.007 | 0.029 | Retinoic acid gamma receptor agonist | |||
| 0.032 | 0.01 | 0.032 | Integrin alpha2beta1 antagonist | |||
| 0.05 | 0.029 | 0.05 | Potassium channel (ATP-sensitive) activator | |||
| 0.028 | 0.006 | 0.028 | Retinoic acid beta receptor agonist | |||
| 0.025 | 0.003 | 0.025 | Integrin beta6 antagonist | |||
| 0.05 | 0.029 | 0.05 | Cholesterol esterase inhibitor | |||
| 0.056 | 0.035 | 0.056 | Epithelial sodium channel blocker | |||
| 0.045 | 0.025 | 0.045 | Erythropoietin receptor agonist | |||
| 0.03 | 0.009 | 0.03 | Integrin beta7 antagonist | |||
| 0.024 | 0.005 | 0.024 | Vitamin D receptor agonist | |||
| 0.025 | 0.005 | 0.025 | Thyroid hormone alpha agonist | |||
| 0.05 | 0.031 | 0.05 | AMPA receptor antagonist | |||
| 0.026 | 0.006 | 0.026 | Kainate receptor 3 antagonist | |||
| 0.037 | 0.018 | 0.037 | Liver X receptor beta agonist | |||
| 0.042 | 0.023 | 0.042 | Aggrecanase 1 inhibitor | |||
| 0.052 | 0.034 | 0.052 | Prolyl endopeptidase inhibitor | |||
| 0.077 | 0.059 | 0.077 | Antineoplastic antibiotic | |||
| 0.052 | 0.034 | 0.052 | CXC chemokine 1 receptor antagonist | |||
| 0.022 | 0.004 | 0.022 | Calcium-dependent phospholipase A2 inhibitor | |||
| 0.05 | 0.032 | 0.05 | Topoisomerase II beta inhibitor | |||
| 0.033 | 0.016 | 0.033 | Endothelin receptor antagonist | |||
| 0.023 | 0.006 | 0.023 | Antibiotic Anthracycline-like | |||
| 0.058 | 0.041 | 0.058 | Aminopeptidase microsomal inhibitor | |||
| 0.056 | 0.04 | 0.056 | Fatty acid synthase inhibitor | |||
| 0.027 | 0.012 | 0.027 | Retinoic acid receptor agonist | |||
| 0.023 | 0.007 | 0.023 | Estrogen-related receptor gamma agonist | |||
| 0.084 | 0.068 | 0.084 | Bromodomain-containing protein 2 inhibitor | |||
| 0.076 | 0.06 | 0.076 | Chymotrypsin inhibitor | |||
| 0.024 | 0.009 | 0.024 | Thymidine kinase (Herpes simplex virus 2) inhibitor | |||
| 0.019 | 0.004 | 0.019 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | |||
| 0.046 | 0.031 | 0.046 | Neurotensin receptor antagonist | |||
| 0.026 | 0.011 | 0.026 | ICAM 1 antagonist | |||
| 0.035 | 0.02 | 0.035 | HCV polyprotein inhibitor | |||
| 0.028 | 0.014 | 0.028 | NMDA receptor glycine site antagonist | |||
| 0.024 | 0.01 | 0.024 | Retinoic acid alpha receptor antagonist | |||
| 0.034 | 0.02 | 0.034 | Catechol O-methyltransferase inhibitor | |||
| 0.028 | 0.014 | 0.028 | Thymidine kinase (Herpes simplex virus 1) inhibitor | |||
| 0.117 | 0.103 | 0.117 | Cytidine deaminase inhibitor | |||
| 0.021 | 0.007 | 0.021 | CXC chemokine 5 receptor antagonist | |||
| 0.052 | 0.038 | 0.052 | Elastase inhibitor | |||
| 0.033 | 0.02 | 0.033 | Cholesterol ester transfer protein antagonist | |||
| 0.019 | 0.007 | 0.139 | Purinergic P2Y1 agonist | 0.139 0.001 DB02912 0.093 0.001 DB04045 0.113 0.001 DB03699 | DB02912 | |
| 0.029 | 0.017 | 0.029 | NMDA 2D receptor antagonist | |||
| 0.034 | 0.023 | 0.034 | Benzodiazepine receptor peripheral-type antagonist | |||
| 0.015 | 0.004 | 0.015 | Thyroid hormone beta agonist | |||
| 0.038 | 0.026 | 0.038 | Carbonic anhydrase I stimulant | |||
| 0.059 | 0.048 | 0.059 | HIV-1 integrase (3'-Processing) inhibitor | |||
| 0.021 | 0.01 | 0.021 | Retinoic acid receptor antagonist | |||
| 0.031 | 0.02 | 0.031 | Cholecystokinin B antagonist | |||
| 0.018 | 0.007 | 0.018 | Integrin alphaVbeta6 antagonist | |||
| 0.056 | 0.046 | 0.056 | Cathepsin E inhibitor | |||
| 0.037 | 0.027 | 0.037 | Cholecystokinin A antagonist | |||
| 0.045 | 0.035 | 0.045 | Potassium channel Kv1.3 blocker | |||
| 0.029 | 0.02 | 0.029 | Liver X receptor alpha antagonist | |||
| 0.037 | 0.028 | 0.037 | DNA gyrase subunit B inhibitor | |||
| 0.028 | 0.018 | 0.028 | Baculoviral IAP repeat-containing protein 4 inhibitor | |||
| 0.012 | 0.003 | 0.012 | Integrin alpha5beta6 antagonist | |||
| 0.108 | 0.099 | 0.108 | Nav1.2 sodium channel blocker | |||
| 0.041 | 0.033 | 0.041 | Histamine H2 receptor agonist | |||
| 0.023 | 0.015 | 0.023 | Angiotensin AT2 receptor antagonist | |||
| 0.074 | 0.066 | 0.074 | Adrenaline agonist | |||
| 0.016 | 0.008 | 0.016 | Egl nine homolog 1 inhibitor | |||
| 0.018 | 0.01 | 0.018 | Tryptophan hydroxylase 1 inhibitor | |||
| 0.123 | 0.115 | 0.123 | Neuropeptide Y1 antagonist | |||
| 0.172 | 0.164 | 0.172 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.039 | 0.031 | 0.039 | Glutamate (mGluR1a) antagonist | |||
| 0.044 | 0.036 | 0.044 | Beta adrenoreceptor agonist | |||
| 0.026 | 0.018 | 0.026 | Acid ceramidase inhibitor | |||
| 0.022 | 0.014 | 0.022 | Angiotensin AT1A receptor antagonist | |||
| 0.026 | 0.019 | 0.026 | CXC chemokine 2 receptor antagonist | |||
| 0.03 | 0.023 | 0.03 | Elastase 2B inhibitor | |||
| 0.03 | 0.023 | 0.03 | Elastase 3B inhibitor | |||
| 0.03 | 0.023 | 0.03 | Elastase 3A inhibitor | |||
| 0.013 | 0.006 | 0.013 | Carboxypeptidase B2 inhibitor | |||
| 0.078 | 0.071 | 0.078 | Myeloperoxidase inhibitor | |||
| 0.034 | 0.028 | 0.034 | Adenosine uptake inhibitor | |||
| 0.058 | 0.053 | 0.058 | Phosphodiesterase 1C inhibitor | |||
| 0.06 | 0.055 | 0.06 | Acetylcholine M5 receptor agonist | |||
| 0.013 | 0.008 | 0.013 | Integrin beta2 antagonist | |||
| 0.016 | 0.01 | 0.016 | Calcium-sensing receptor antagonist | |||
| 0.025 | 0.02 | 0.025 | Thymidine phosphorylase inhibitor | |||
| 0.013 | 0.007 | 0.013 | Egl nine homolog 3 inhibitor | |||
| 0.011 | 0.006 | 0.011 | Angiotensin AT2 receptor agonist | |||
| 0.011 | 0.006 | 0.011 | Integrin alphaVbeta5 antagonist | |||
| 0.049 | 0.044 | 0.049 | Vanilloid 2 antagonist | |||
| 0.02 | 0.015 | 0.02 | Toll-Like receptor 8 agonist | |||
| 0.033 | 0.029 | 0.033 | AMPA receptor agonist | |||
| 0.008 | 0.004 | 0.008 | Phosphoribosylglycinamide formyltransferase inhibitor | |||
| 0.084 | 0.081 | 0.084 | Protease inhibitor | |||
| 0.024 | 0.021 | 0.024 | Sodium/glucose cotransporter inhibitor | |||
| 0.021 | 0.018 | 0.021 | Geranylgeranyltransferase inhibitor | |||
| 0.041 | 0.038 | 0.041 | Histamine H1 receptor agonist | |||
| 0.035 | 0.032 | 0.035 | Alpha 1d adrenoreceptor agonist | |||
| 0.024 | 0.022 | 0.024 | Complement factor 1s inhibitor | |||
| 0.024 | 0.022 | 0.024 | Sodium/glucose cotransporter 2 inhibitor | |||
| 0.019 | 0.017 | 0.019 | Endothelin A receptor antagonist | |||
| 0.016 | 0.015 | 0.016 | Endothelin B receptor antagonist | |||
| 0.059 | 0.058 | 0.059 | Prolactin release inhibitor | |||
| 0.02 | 0.019 | 0.02 | Protease (Human cytomegalovirus) inhibitor | |||
| 0.079 | 0.079 | 0.143 | Phosphodiesterase I inhibitor | 0.143 0.019 DB02912 0.102 0.042 DB04045 0.092 0.056 DB03699 | DB02912 | |
| 0.016 | 0.015 | 0.016 | Angiotensin-converting enzyme 2 inhibitor | |||
| 0.01 | 0.012 | 0.011 | Purine nucleoside phosphorylase inhibitor | 0.011 0.009 DB02912 0.011 0.01 DB03699 | DB03699 | |
| 0.031 | 0.034 | 0.036 | Growth factor receptor-bound protein 2 antagonist | 0.034 0.027 DB02912 0.036 0.021 DB04045 0.035 0.025 DB03699 | DB04045 | |
| 0.015 | 0.02 | 0.02 | Inosine monophosphate dehydrogenase 2 inhibitor | 0.02 0.014 DB03699 | DB03699 | |
| 0.008 | 0.015 | 0.013 | Purinergic P2Y2 agonist | 0.013 0.004 DB02912 0.01 0.008 DB04045 0.011 0.006 DB03699 | DB02912 | |
| 0.023 | 0.03 | 0.048 | Toll-Like receptor 4 agonist | 0.048 0.004 DB02912 0.045 0.004 DB04045 0.048 0.004 DB03699 | DB03699 | |
| 0.01 | 0.039 | 0.076 | Inosine monophosphate dehydrogenase 1 inhibitor | 0.076 0.003 DB02912 0.069 0.003 DB04045 0.074 0.003 DB03699 | DB02912 | |
| 0.011 | 0.048 | 0.023 | Adenosine A3 receptor agonist | 0.023 0.007 DB02912 0.021 0.008 DB04045 0.022 0.007 DB03699 | DB02912 | |
| 0.025 | 0.065 | 0.033 | Antibiotic Aminoglycoside-like | 0.033 0.032 DB02912 | DB02912 | |
| 0.009 | 0.064 | 0.037 | Adenosine kinase inhibitor | 0.037 0.008 DB02912 0.019 0.017 DB03699 | DB02912 | |
| 0.021 | 0.078 | 0.096 | Purinergic P2Y2 antagonist | 0.096 0.004 DB02912 0.089 0.005 DB04045 0.093 0.004 DB03699 | DB02912 | |
| 0 | 0.076 | 0.008 | Purinergic P2Y4 agonist | 0.008 0.002 DB02912 0.007 0.002 DB04045 0.007 0.002 DB03699 | DB02912 | |
| 0.003 | 0.08 | 0.068 | Purinergic P2Y agonist | 0.068 0.002 DB02912 0.06 0.002 DB04045 0.063 0.002 DB03699 | DB02912 | |
| 0.003 | 0.084 | 0.078 | Purinergic receptor agonist | 0.078 0.002 DB02912 0.07 0.002 DB04045 0.072 0.002 DB03699 | DB02912 | |
| 0.003 | 0.084 | 0.078 | Purinergic P2 agonist | 0.078 0.002 DB02912 0.07 0.002 DB04045 0.072 0.002 DB03699 | DB02912 | |
| 0.007 | 0.118 | 0.023 | S-adenosyl-L-homocysteine hydrolase inhibitor | 0.023 0.005 DB02912 0.021 0.006 DB04045 0.022 0.006 DB03699 | DB02912 | |
| 0.105 | 0.226 | 0.512 | Tumour necrosis factor alpha release inhibitor | 0.512 0.013 DB02912 0.419 0.024 DB04045 0.394 0.028 DB03699 | DB02912 | |
| 0.023 | 0.168 | 0.216 | Purinergic P2 antagonist | 0.216 0.006 DB02912 0.202 0.007 DB04045 0.21 0.006 DB03699 | DB02912 | |
| 0.006 | 0.182 | 0.13 | Purinergic P2X agonist | 0.13 0.002 DB02912 0.117 0.003 DB04045 0.121 0.003 DB03699 | DB02912 | |
| 0.005 | 0.238 | 0.063 | Adenosine A1 receptor agonist | 0.063 0.005 DB02912 0.053 0.005 DB04045 0.055 0.005 DB03699 | DB02912 | |
| 0.005 | 0.327 | 0.02 | Adenosine A2b receptor agonist | 0.02 0.006 DB02912 0.018 0.007 DB04045 0.018 0.006 DB03699 | DB02912 | |
| 0.013 | 0.357 | 0.203 | Purinergic P2X2 antagonist | 0.203 0.004 DB02912 0.196 0.005 DB04045 0.195 0.005 DB03699 | DB02912 | |
| 0.019 | 0.46 | 0.06 | Antiviral (Hepatitis D) | 0.06 0.022 DB02912 0.059 0.023 DB04045 0.056 0.026 DB03699 | DB02912 | |
| 0.009 | 0.5 | 0.062 | HIV-1 reverse transcriptase inhibitor | 0.06 0.058 DB02912 0.062 0.056 DB03699 | DB03699 | |
| 0.003 | 0.533 | 0.146 | Purinergic P2Y1 antagonist | 0.146 0.002 DB02912 0.101 0.003 DB04045 0.108 0.002 DB03699 | DB02912 | |
| 0.013 | 0.695 | 0.167 | DNA directed RNA polymerase inhibitor | 0.167 0.019 DB02912 0.144 0.026 DB04045 0.159 0.022 DB03699 | DB02912 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |